Cargando…

Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis

The use of TNF-alpha antagonists (infliximab, etanercept, adalimumab) has changed the course of many rheumatic diseases including rheumatoid arthritis (RA). Since their approval, some questions regarding their safety including infections have been observed. The aim of the study was to evaluate the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benucci, M, Saviola, G, Baiardi, P, Manfredi, M, Sarzi Puttini, P, Atzeni, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362853/ https://www.ncbi.nlm.nih.gov/pubmed/22655000 http://dx.doi.org/10.2174/1874312901206010033

Ejemplares similares

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015)

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment
por: Atzeni, Fabiola, et al.
Publicado: (2019)

Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry
por: Filippini, Matteo, et al.
Publicado: (2014)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci, Maurizio, et al.
Publicado: (2016)

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005)

Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2002)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
por: Benucci, Maurizio, et al.
Publicado: (2016)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018)

Comparison of Efficacy of Ketoprofen and Ibuprofen in Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019)

Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis
por: Ferraccioli, Gianfranco, et al.
Publicado: (2012)

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
por: Talotta, Rossella, et al.
Publicado: (2017)

Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures
por: Salaffi, Fausto, et al.
Publicado: (2021)

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
por: Benucci, Maurizio, et al.
Publicado: (2021)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
por: Ursini, Francesco, et al.
Publicado: (2017)

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B
por: Infantino, M., et al.
Publicado: (2013)

Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
por: Atzeni, Fabiola, et al.
Publicado: (2006)

Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results
por: Süha, Çetin, et al.
Publicado: (2014)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
por: Cimmino, Marco A, et al.
Publicado: (2020)

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
por: Batticciotto, Alberto, et al.
Publicado: (2016)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
por: Aaltonen, Kalle J., et al.
Publicado: (2012)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
por: Fragoulakis, Vasilis, et al.
Publicado: (2015)

Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats
por: Caruso, Innocenzo, et al.
Publicado: (2016)

Doctors' Insights into the Patient Perspective: A Qualitative Study in the Field of Chronic Pain
por: Zanini, Claudia, et al.
Publicado: (2014)

Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts
por: Zanini, Claudia, et al.
Publicado: (2015)

TCD4(pos) lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2017)

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
por: Emery, P, et al.
Publicado: (2015)

Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy
por: Anghel, Daniela, et al.
Publicado: (2023)

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
por: Schwartzman, Sergio, et al.
Publicado: (2004)

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
por: Atzeni, Fabiola, et al.
Publicado: (2008)

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
por: Salaffi, Fausto, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7eughettnhllove9co2hjj0pit